AKBA — Akebia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Akebia Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K/A	10-Q	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	148	269	150	90.5	42.9
Net Total Accounts Receivable
Net Total Receivables	38.9	26.9	51.6	40.3	39.3
Total Inventory
Prepaid Expenses
Total Current Assets	310	371	271	185	118
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39.4	35.5	40.6	34.4	16
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	771	644	529	356	242
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	208	187	261	130	99.9
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	376	397	455	351	272
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	395	248	74	5.23	-30.6
Total Liabilities & Shareholders' Equity	771	644	529	356	242
Total Common Shares Outstanding